2,409
Participants
Start Date
December 12, 2013
Primary Completion Date
October 3, 2017
Study Completion Date
November 3, 2021
Nasal swab sampling
Nasal swab samples will be collected from subjects at each examination visit, if they develop respiratory tract infection symptoms with difficulty in breathing and are called for an examination visit in the study.
Blood sampling
A single blood sample will be collected from a sub-cohort consisting of the first 2000 enrolled subjects when they are either 2, 4, 6, 12, 18 or 24 months old.
Diary cards
Diary cards will be provided to parents or LARs of the subjects to record RTI/LRTI, wheeze and asthma symptoms.
GSK Investigational Site, Dhaka
GSK Investigational Site, Soweto
GSK Investigational Site, Río Cuarto
GSK Investigational Site, Bangkok
GSK Investigational Site, Pathum Thani
GSK Investigational Site, Syracuse
GSK Investigational Site, San Pedro Sula
GSK Investigational Site, San Pedro Sula
GSK Investigational Site, Pori
GSK Investigational Site, Khon Kaen
GSK Investigational Site, Seinäjoki
GSK Investigational Site, Kokkola
GSK Investigational Site, Roy
GSK Investigational Site, Syracuse
GSK Investigational Site, Oulu
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Oakland
GSK Investigational Site, Santa Clara
GSK Investigational Site, Sacramento
GSK Investigational Site, Sacramento
GSK Investigational Site, Seattle
GSK Investigational Site, Ciudad de Buenos Aires
GSK Investigational Site, Halifax
Lead Sponsor
GlaxoSmithKline
INDUSTRY